Justin Zelin

Stock Analyst at BTIG

(2.53)
# 2,409
Out of 5,044 analysts
45
Total ratings
31.11%
Success rate
0.35%
Average return

Stocks Rated by Justin Zelin

Syndax Pharmaceuticals
Oct 27, 2025
Reiterates: Buy
Price Target: $56
Current: $13.51
Upside: +314.51%
I-Mab
Oct 24, 2025
Reiterates: Buy
Price Target: $9
Current: $4.64
Upside: +93.97%
IDEAYA Biosciences
Oct 21, 2025
Reiterates: Buy
Price Target: $62
Current: $33.19
Upside: +86.80%
Canaan
Oct 14, 2025
Reiterates: Buy
Price Target: $8
Current: $1.45
Upside: +451.72%
Viking Therapeutics
Sep 22, 2025
Reiterates: Buy
Price Target: $125
Current: $34.93
Upside: +257.86%
Jasper Therapeutics
Sep 22, 2025
Maintains: Buy
Price Target: $20$7
Current: $2.34
Upside: +199.15%
Verastem
Sep 9, 2025
Reiterates: Buy
Price Target: $20
Current: $8.85
Upside: +125.99%
ImmunityBio
Jan 10, 2025
Initiates: Buy
Price Target: $6
Current: $2.58
Upside: +132.56%
Enliven Therapeutics
Dec 13, 2024
Initiates: Buy
Price Target: $42
Current: $21.55
Upside: +94.90%
TScan Therapeutics
May 16, 2024
Initiates: Buy
Price Target: $12
Current: $2.13
Upside: +463.38%
Downgrades: Neutral
Price Target: n/a
Current: $5.94
Upside: -
Maintains: Buy
Price Target: $1,000$800
Current: $1.50
Upside: +53,233.33%
Maintains: Buy
Price Target: $85$91
Current: $33.75
Upside: +169.63%
Maintains: Buy
Price Target: $20$10
Current: $0.86
Upside: +1,068.77%
Initiates: Buy
Price Target: $16
Current: $3.04
Upside: +426.32%
Maintains: Buy
Price Target: $30$37
Current: $14.84
Upside: +149.33%
Maintains: Buy
Price Target: $85$90
Current: $32.57
Upside: +176.33%
Initiates: Buy
Price Target: $31
Current: $10.51
Upside: +194.96%
Maintains: Buy
Price Target: $10$16
Current: $52.05
Upside: -70.22%
Maintains: Buy
Price Target: $21$10
Current: $1.58
Upside: +532.91%